Published on: 2024-07651. Final rule. 2024-07651. Poison Prevention Packaging Requirements; Exemption of Baloxavir Marboxil Tablets in Packages Containing Not More Than 80 mg of the Drug
Published on: 2021-19953. Notice of proposed rulemaking. 2021-19953. Poison Prevention Packaging Requirements; Proposed Exemption of Baloxavir Marboxil Tablets in Packages Containing Not More Than 80 mg of the Drug
Published on: 2012-29203. Final rule. 2012-29203. Requirements for Child-Resistant Packaging: Products Containing Imidazolines Equivalent to 0.08 Milligrams or More
Published on: 2011-18511. Final rule. 2011-18511. Poison Prevention Packaging Requirements; Exemption of Powder Formulations of Colesevelam Hydrochloride and Sevelamer Carbonate
Published on: 2011-3437. Proposed rule. 2011-3437. Poison Prevention Packaging Requirements; Proposed Exemption of Powder Formulations of Colesevelam Hydrochloride and Sevelamer Carbonate